Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Liquid medicine for preventing and treating allergic rhinitis and wet tissue or tissue prepared by applying liquid medicine

A technology for allergic rhinitis and liquid medicine, which is applied in the field of liquid medicine, wet wipes or paper towels for the prevention and treatment of allergic rhinitis. It can solve the problems of drug-induced rhinitis, single function, and inability to completely cure inflammation, so as to prevent and alleviate allergies The effect of treating rhinitis attack, protecting nasal mucosa, and relieving red eyes and tears

Active Publication Date: 2014-09-03
张大威 +1
View PDF6 Cites 16 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Because oral drugs need to be absorbed through the human gastrointestinal tract and transported through the blood to produce curative effects, most of them can only temporarily control and relieve symptoms, but cannot eradicate them, and have many side effects
[0008] (2) Intranasal spray: the spray containing cromolyn sodium is only effective for the prevention of allergic rhinitis, but the effect is poor for patients who have developed it; sympathomimetic preparations are only effective for relieving nasal congestion symptoms, but cannot completely cure inflammation : Steroid-containing preparations can relieve symptoms in a short period of time, but long-term use has large side effects, which can easily cause drug-induced rhinitis
And present existing wet wipes and paper towels generally all are pure cleaning purpose, and function is single, are mainly used for cleaning people's face, hands and articles, do not yet possess therapeutic effect, especially are used for the wet wipes or the prevention and treatment of allergic rhinitis. Paper towels and similar products

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Liquid medicine for preventing and treating allergic rhinitis and wet tissue or tissue prepared by applying liquid medicine
  • Liquid medicine for preventing and treating allergic rhinitis and wet tissue or tissue prepared by applying liquid medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0100] A wet tissue for preventing and treating allergic rhinitis, the wet tissue includes a carrier material and the above-mentioned medicinal solution. Wherein, the carrier material is a non-woven fabric; the medicinal solution also includes 1 part of additive A, and the additive A includes 0.1 part of an osmotic pressure regulator, 0.1 part of a moisturizing agent, 0.1 part of a transdermal absorption accelerator, and a pH regulator 0.05 part, 0.05 part of latent solvent, 0.05 part of antioxidant and 0.55 part of antibacterial agent; The osmotic pressure regulator is sodium chloride; The moisturizing agent is liquid paraffin; The transdermal absorption accelerator is dimethyl sulfoxide; the pH regulator is a mixture of disodium hydrogen phosphate and sodium dihydrogen phosphate in a weight ratio of 1:0.8; the latent solvent is glycerol; the antioxidant is butyl Hydroxytoluene; Described bacteriostatic agent is methyl p-hydroxybenzoate.

[0101] A preparation method for wet...

Embodiment 2

[0110]A wet tissue for preventing and treating allergic rhinitis, the wet tissue includes a carrier material and the above-mentioned medicinal solution. Wherein, the carrier material is a non-woven fabric; the medicinal solution also includes 1.3 parts of additive A, and the additive A includes 0.1 part of an osmotic pressure regulator, 0.1 part of a moisturizing agent, 0.2 parts of a transdermal absorption accelerator, and a pH regulator 0.1 part, 0.1 part of latent solvent, 0.1 part of antioxidant and 0.6 part of antibacterial agent; The osmotic pressure regulator is potassium chloride; The moisturizing agent is hyaluronic acid; The transdermal absorption accelerator is Azone; The pH regulator is a mixture of disodium hydrogen phosphate and sodium dihydrogen phosphate at a weight ratio of 1:1; the latent solvent is ethanol; the antioxidant is butyl hydroxyanisole; the bacteriostatic agent is Ethylparaben.

[0111] A preparation method for wet wipes for preventing and treati...

Embodiment 3

[0120] A wet tissue for preventing and treating allergic rhinitis, the wet tissue includes a carrier material and the above-mentioned medicinal solution. Wherein, the carrier material is a non-woven fabric; the medicinal solution also includes 1.5 parts of additive A, and the additive A includes 0.1 part of an osmotic pressure regulator, 0.2 part of a moisturizing agent, 0.1 part of a transdermal absorption accelerator, and a pH regulator 0.2 part, 0.1 part of latent solvent, 0.2 part of antioxidant and 0.6 part of antibacterial agent; The osmotic pressure regulator is sodium acetate; The humectant is sorbitol; The transdermal absorption accelerator is polyethylene glycol The pH regulator is a mixture of disodium hydrogen phosphate and sodium dihydrogen phosphate in a weight ratio of 1:1.2; the latent solvent is propylene glycol; the antioxidant is butylated hydroxyanisole; The bacteriostatic agent is propylparaben.

[0121] A preparation method for wet wipes for preventing a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of medicine application, and particularly relates to a liquid medicine for preventing and treating allergic rhinitis and wet tissue or tissue prepared by applying the liquid medicine. The liquid medicine is prepared from the following raw materials in parts by weight: 10-90 parts of magnolia flower, 5-40 parts of centipeda minima and 5-40 parts of cocklebur fruit. The wet tissue and tissue for preventing and treating allergic rhinitis by applying the liquid medicine are prepared from natural skin-friendly non-irritative materials, comprise a plurality of traditional Chinese medicinal effective components with the effects of resisting rhinitis and restoring nasal cavity, and are used for preventing and relieving discomfort of the nose of a patient with allergic rhinitis in daily life and non-invasively cleaning snot and other excretions when rhinitis attacks. Traditional Chinese medicine is developed to the tissue mode which is concise and convenient, the tissue has good application value and market prospect, is advantageous to popularize modern application of traditional Chinese medicines, and is beneficial to pain relieving of patients with allergic rhinitis.

Description

technical field [0001] The invention relates to the technical field of medicine application, in particular to a medicine solution for preventing and treating allergic rhinitis and a wet tissue or paper tissue prepared by using the medicine solution. Background technique [0002] Rhinitis is a common and frequently-occurring disease, and the age of onset tends to be younger. Rhinitis refers to inflammation of the nasal mucosa, manifested as congestion or edema. Patients often have symptoms such as nasal congestion, runny nose, nasal itching, throat discomfort, coughing, etc. Epidemiological surveys show that the prevalence rate is about 15%. , the headache that brings, stuffy nose, sneezing have a strong impact on patient's quality of life. Rhinitis is the most common with chronic rhinitis and allergic rhinitis (also claiming allergic rhinitis). Although the clinical symptoms of rhinitis morbidity are different, the harm is great, it seriously perplexes patients, and has a ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/575A61K9/00A61P11/02A61P37/08
Inventor 张大威沈嘉
Owner 张大威
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products